Northwestern University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).
Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.
Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.
Top-decile sponsor footprint
Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,209 total, page 1 of 25
Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males
NCT07604272
ARPA-H Smart Band-Aid to Measure Chronic Pain in Women
NCT06994988
The REACH-OUT Trial
NCT07540143
MINT Conditioning to Improve Gait
NCT07041775
Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury
NCT07224165
Design and Feasibility of an SMS-based Safety Planning Intervention
NCT07365579
PREcision MEDicine In Achalasia (PREMEDIA) - Cohort
NCT07293689
Pediatricians Building Resilience Through Early Identification for Toddler Well-Being
NCT07091240
Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program
NCT07669753
Ejaculatory-Sparing HoLEP vs Standard HoLEP
NCT07631286
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
NCT07632742
Trial in HPV Prevention for the U.S. Vietnamese Community
NCT07637630
Genicular Artery Embolization for Knee Osteoarthritis
NCT07537153
Comparing Efficiency and Stone-Free Rates Mini PCNL vs Flex URS
NCT07072598
Effects of Transcutaneous Vagal Nerve Stimulation on Post-Surgical Return to Consciousness, Delirium, and Depression
NCT07610655
PREcision MEDicine In Achalasia (PREMEDIA)
NCT07293650
Choice and Autonomy in Learning Mindfulness for Pediatric Residents
NCT07542769
Experimental Evidence of the Impact of Parental Income on Child Mental Health and Neuroimmune Function
NCT07641244
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy for Dizziness
NCT07225023
Watchful Waiting Versus Immediate Repair for Occult Contralateral Inguinal Hernias.
NCT07461558
Procedural Framing and Epidural Steroid Injection Outcomes
NCT07498140
Northwestern Neuromuscular Disease Biorepository
NCT07477509
Empower EI: Comparing Early Intervention Approaches to Improve Communication in Toddlers With Developmental Delays
NCT07227974
Cytokine Response to Abdominal Wall Reconstruction
NCT07422584
FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial
NCT06062888
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
NCT07427017
Sleep, Dreaming, and Virtual Reality for Mental Health
NCT07408206
Family Navigator Plus for Foster Parents
NCT06978959
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy
NCT07224945
Upadacitinib as a Novel Treatment for Refractory Eyelid Dermatitis
NCT06684522
Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy
NCT07286188
Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
NCT07178301
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
NCT07225361
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
NCT07207148
Partnering With Antenatal Navigators to Transform Health in Pregnancy
NCT06941974
Community-based Approach to Lowering Stress Through Mindfulness
NCT06987799
Emotional Well-being and Measures of Healthy Aging
NCT07334106
Pupillometry in Delayed Sleep Wake Phase Disorder
NCT06949644
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
NCT06698146
Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors
NCT07290543
Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma
NCT07050186
Improving Mobility After Revascularization in Peripheral Artery Disease
NCT06686121
Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)
NCT06804785
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
NCT03932903
Personalized Theta-burst Stimulation for Long-lasting Changes in Approach/Avoidance Behavior
NCT07161505
Test of Target Engagement of Ambiguity Aversion
NCT06962527
SAGE LEAF 2: An Online Program to Reduce Dementia Caregiver Burden
NCT06708182
Ketamine, SGB and Combination Treatment for TBI
NCT06608277
Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma
NCT06169280
Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs
NCT06912776
What is open in the Northwestern University pipeline
187 recruiting of 1,209 indexed (15% open); 767 completed (63%).
Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).
Top condition: Depression (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Northwestern University: open-pipeline peers nationwide
Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,209 trials (± recruiting share)
- Emory University · 1,208 trials · 17% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Brigham and Women's Hospital · 15% recruiting · 937 trials
- Incyte Corporation · 15% recruiting · 239 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Northwestern University page
1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.
- 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Northwestern University pipeline card: 1,209 registered trials from official public datasets.Report a data error.